Jinwon Life Sciences is trading at 10,200 KRW as of 10:31 AM on the 25th, the same price as the previous day. This represents a 26.62% decrease compared to April 23. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Today, foreigners are tentatively recorded as net buyers of 10,607 shares. Over the past five days, individual investors have been net sellers of 47,534 shares, while foreigners and institutions have been net buyers of 24,704 shares and 1,075 shares, respectively.

On May 21, Jinwon Life Sciences became a market issue with the news "US Inovio COVID-19 vaccine induces antibody formation in mice."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing